Information Provided By: 
Fly News Breaks for April 5, 2016
BABY
Apr 5, 2016 | 08:20 EDT
Roth Capital analyst Chris Lewis lowered his price target for Natus Medical to $39 from $44, following preannounced weaker than expected Q1 sales, pointing to pushouts of key orders in both International and domestic markets late in the quarter. Lewis recommends investors to be cautious in the near-term. However, the analyst still believes the company's core strategic value, emerging service businesses, and margin expansion opportunities present long-term upside. Lewis reiterates a Buy rating on the shares.
News For BABY From the Last 2 Days
There are no results for your query BABY
